Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARTIS: 18F-sodium Fluoride PET/MR in Carotid Plaque
NCT02726984Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium fluoride f-18 in carotid atheroma (CAS) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoints: Standardized Uptake Value at 15 days and Tissue-to-Background Ratio at 15 days. Started Jan 2016; status: completed.
02
Drugs
sodium fluoride f-18
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT02726984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726984.